Overview

Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia

Status:
Not yet recruiting

Trial end date:
2023-12-31

Target enrollment:

Participant gender:

Summary

The objectives of this study are: To evaluate the safety and efficacy of Nyxol alone and with adjunctive low dose pilocarpine to improve distance-corrected near visual acuity (DCNVA) in subjects with presbyopia.

Phase:

Phase 3

Details

Lead Sponsor:

Ocuphire Pharma, Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions
Phentolamine
Pilocarpine